Book Description
A good alternative to PDR for the layman wanting to check on pharmaceuticals. Annotation copyrighted by Book News, Inc., Portland, OR
Author : Edward L. Stern
Publisher : Perigee Books
Page : 0 pages
File Size : 33,5 MB
Release : 1993
Category : Chemotherapy
ISBN : 9780399518058
A good alternative to PDR for the layman wanting to check on pharmaceuticals. Annotation copyrighted by Book News, Inc., Portland, OR
Author : Donald Light
Publisher : Columbia University Press
Page : 179 pages
File Size : 14,58 MB
Release : 2010
Category : Business & Economics
ISBN : 0231146922
Few people realize that prescription drugs have become a leading cause of death, disease, and disability. Adverse reactions to widely used drugs, such as psychotropics and birth control pills, as well as biologicals, result in FDA warnings against adverse reactions. The Risks of Prescription Drugs describes how most drugs approved by the FDA are under-tested for adverse drug reactions, yet offer few new benefits. Drugs cause more than 2.2 million hospitalizations and 110,000 hospital-based deaths a year. Serious drug reactions at home or in nursing homes would significantly raise the total. Women, older people, and people with disabilities are least used in clinical trials and most affected. Health policy experts Donald Light, Howard Brody, Peter Conrad, Allan Horwitz, and Cheryl Stults describe how current regulations reward drug companies to expand clinical risks and create new diseases so millions of patients are exposed to unnecessary risks, especially women and the elderly. They reward developing marginally better drugs rather than discovering breakthrough, life-saving drugs. The Risks of Prescription Drugs tackles critical questions about the pharmaceutical industry and the privatization of risk. To what extent does the FDA protect the public from serious side effects and disasters? What is the effect of giving the private sector and markets a greater role and reducing public oversight? This volume considers whether current rules and incentives put patients' health at greater risk, the effect of the expansion of disease categories, the industry's justification of high U.S. prices, and the underlying shifts in the burden of risk borne by individuals in the world of pharmaceuticals. Chapters cover risks of statins for high cholesterol, SSRI drugs for depression and anxiety, and hormone replacement therapy for menopause. A final chapter outlines six changes to make drugs safer and more effective. Suitable for courses on health and aging, gender, disability, and minority studies, this book identifies the Risk Proliferation Syndrome that maximizes the number of people exposed to these risks. Additional Columbia / SSRC books on the privatization of risk and its implications for Americans: Bailouts: Public Money, Private ProfitEdited by Robert E. Wright Disaster and the Politics of InterventionEdited by Andrew Lakoff Health at Risk: America's Ailing Health System-and How to Heal ItEdited by Jacob S. Hacker Laid Off, Laid Low: Political and Economic Consequences of Employment InsecurityEdited by Katherine S. Newman Pensions, Social Security, and the Privatization of RiskEdited by Mitchell A. Orenstein
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 235 pages
File Size : 38,2 MB
Release : 2018-03-01
Category : Medical
ISBN : 0309468086
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author : Edward R. Brace
Publisher :
Page : 196 pages
File Size : 34,45 MB
Release : 1980
Category : Medical
ISBN : 9780716620587
Author : Steven Woloshin
Publisher : Univ of California Press
Page : 154 pages
File Size : 19,75 MB
Release : 2008-11-30
Category : Family & Relationships
ISBN : 0520252225
Understanding risk -- Putting risk in perspective -- Risk charts : a way to get perspective -- Judging the benefit of a health intervention -- Not all benefits are equal : understand the outcome -- Consider the downsides -- Do the benefits outweight the downsides? -- Beware of exaggerated importance -- Beware of exaggerated certainty -- Who's behind the numbers?
Author : Armon B. Neel (Jr.)
Publisher : Simon and Schuster
Page : 297 pages
File Size : 36,32 MB
Release : 2012-07-03
Category : Family & Relationships
ISBN : 145160839X
A veteran board-certified pharmacist cites the high number of annual deaths associated with prescription drug side effects, calling for changes in prescription practices that account for the needs of aging bodies.
Author : Michael Mancano
Publisher : Jones & Bartlett Learning
Page : 272 pages
File Size : 27,63 MB
Release : 2010-11-12
Category : Medical
ISBN : 0763781177
Health Sciences & Professions
Author : United States. General Accounting Office
Publisher :
Page : 12 pages
File Size : 47,63 MB
Release : 2001
Category : Drugs
ISBN :
Author : Frank W. Cawood and Associates
Publisher : FC&A Publishing
Page : 498 pages
File Size : 22,65 MB
Release : 1998
Category : Health & Fitness
ISBN :
Author : Roma Harris
Publisher : Praeger
Page : 200 pages
File Size : 35,2 MB
Release : 1994-08-16
Category : Family & Relationships
ISBN :
Ordinary citizens face a frustrating and increasingly complex maze of human service agencies when they seek help for everyday problems, even though one stop information and referral centers have been established to facilitate information seeking in many communities. This book explores the relationship between the information needs of battered women and the information response provided through social networks in six communities of varying size. The book is based on an award-winning study, in which 543 women described their knowledge of the problem of woman abuse and what kinds of information resources would be helpful to an abused woman. In the second phase of the study, 179 interviews were conducted with service providers identified by these women as likely sources of help. A comparison of the interviews demonstrates that the response of information delivery systems does not adequately meet the needs and expectations of those women who would seek such services. The final chapters of the volume focus on the implications of this study for the design of social service systems.